USD 1.78
(1.72%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 29.81 Thousand CAD | -59.07% |
2022 | 72.85 Thousand CAD | -78.55% |
2021 | 339.66 Thousand CAD | 14323.18% |
2020 | 2355.00 CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 5489.00 CAD | -4.66% |
2023 Q1 | 33.1 Thousand CAD | 34.85% |
2023 FY | 29.81 Thousand CAD | -59.07% |
2023 Q4 | 5757.00 CAD | -53.64% |
2023 Q3 | 12.41 Thousand CAD | 6.67% |
2023 Q2 | 11.64 Thousand CAD | -64.84% |
2022 Q3 | 15.2 Thousand CAD | 0.0% |
2022 Q4 | 24.55 Thousand CAD | 61.51% |
2022 FY | 72.85 Thousand CAD | -78.55% |
2022 Q1 | 33.1 Thousand CAD | -79.52% |
2022 Q2 | - CAD | -100.0% |
2021 Q3 | 555.09 Thousand CAD | 269.71% |
2021 Q4 | 161.61 Thousand CAD | -70.88% |
2021 Q2 | 150.14 Thousand CAD | 0.0% |
2021 Q1 | - CAD | -100.0% |
2021 FY | 339.66 Thousand CAD | 14323.18% |
2020 Q1 | - CAD | 0.0% |
2020 FY | 2355.00 CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | 2355.00 CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Akoya Biosciences, Inc. | 96.63 Million USD | 99.969% |
AngioDynamics, Inc. | 303.91 Million USD | 99.99% |
AtriCure, Inc. | 399.24 Million USD | 99.993% |
Avinger, Inc. | 7.65 Million USD | 99.61% |
Azenta, Inc. | 665.07 Million USD | 99.996% |
BioLife Solutions, Inc. | 143.27 Million USD | 99.979% |
The Cooper Companies, Inc. | 3.59 Billion USD | 99.999% |
Daxor Corporation | 1.28 Million USD | 97.672% |
Ekso Bionics Holdings, Inc. | 18.27 Million USD | 99.837% |
Femasys Inc. | 1.07 Million USD | 97.219% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 112.25 Million USD | 99.973% |
Hologic, Inc. | 4.03 Billion USD | 99.999% |
ICU Medical, Inc. | 2.25 Billion USD | 99.999% |
Intuitive Surgical, Inc. | 7.12 Billion USD | 100.0% |
KORU Medical Systems, Inc. | 28.51 Million USD | 99.895% |
LeMaitre Vascular, Inc. | 193.48 Million USD | 99.985% |
Innovative Eyewear, Inc. | 1.15 Million USD | 97.413% |
Innovative Eyewear, Inc. | 1.15 Million USD | 97.413% |
Masimo Corporation | 2.04 Billion USD | 99.999% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 99.969% |
Merit Medical Systems, Inc. | 1.25 Billion USD | 99.998% |
Nephros, Inc. | 14.23 Million USD | 99.791% |
NovoCure Limited | 509.33 Million USD | 99.994% |
NEXGEL, Inc. | 4.08 Million USD | 99.271% |
NEXGEL, Inc. | 4.08 Million USD | 99.271% |
Singular Genomics Systems, Inc. | 2.91 Million USD | 98.976% |
OraSure Technologies, Inc. | 405.47 Million USD | 99.993% |
Pro-Dex, Inc. | 53.84 Million USD | 99.945% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 1.78 Million USD | 98.325% |
Precision Optics Corporation, Inc. | 19.1 Million USD | 99.844% |
QuidelOrtho Corporation | 2.99 Billion USD | 99.999% |
Repligen Corporation | 638.76 Million USD | 99.995% |
Sanara MedTech Inc. | 64.98 Million USD | 99.954% |
STAAR Surgical Company | 322.41 Million USD | 99.991% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 50.22 Million USD | 99.941% |
DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.999% |
Jin Medical International Ltd. | 19.82 Million USD | 99.85% |